Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.

@article{Mannavola2005DifferentRT,
  title={Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.},
  author={Deborah Mannavola and Luca Persani and Guia M Vannucchi and Maddalena Zanardelli and Laura Fugazzola and Uberta Verga and Marco Facchetti and Paolo Beck-Peccoz},
  journal={Clinical endocrinology},
  year={2005},
  volume={62 2},
  pages={176-81}
}
OBJECTIVE Central hyperthyroidism is mainly due to two different causes, TSH-secreting pituitary adenoma (TSH-oma) and resistance to thyroid hormone in its pituitary variant, i.e. patients presenting with signs and symptoms of hyperthyroidism (PRTH). Because therapeutic approach and the clinical follow-up are extremely different in these two disorders, a correct differential diagnosis is mandatory. Unfortunately, no definite pathognomonic tool is presently available and an extensive biochemical… CONTINUE READING
21 Citations
0 References
Similar Papers

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…